Amyloid
-
Patient’s efforts help shine light on plasma cell disorder
Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease. Read MoreApr 5, 2018
-
Alzheimer’s proteins in ICU survivors
The cognitive impairment that affects patients who survive a stay in the ICU does not appear to have a similar mechanism to Alzheimer’s disease, Vanderbilt researchers have discovered. Read MoreMar 27, 2018
-
Vitamin C deficiency and mitochondrial dysfunction in Alzheimer’s disease
Recent findings suggest that vitamin C deficiency could contribute to Alzheimer’s disease, suggesting that avoiding deficiency through diet and supplementation could protect against disease onset. Read MoreDec 1, 2017
-
Protein structure may aid in treating Alzheimer’s disease
A new protein structure may guide the development of Alzheimer's therapeutics. Read MoreApr 27, 2017
-
Multidisciplinary team takes on rare plasma cell disorder
The Vanderbilt Amyloid Multidisciplinary Program (VAMP) is a new approach to treating a rare and misunderstood disease that can kill its victims before they understand what they have been diagnosed with. Read MoreDec 6, 2012
-
Alzheimer’s protein structure suggests new treatment directions
The molecular structure of a protein involved in Alzheimer’s disease – and the surprising discovery that it binds cholesterol – could lead to new therapeutics for the memory-robbing disease. Read MoreMay 31, 2012